Ken Coyle

Biography

Ken Coyle has led the Radius Sales organization since January 2016, and has more that 20 years of U.S. and global experience in multiple organizations, functions and therapeutic areas, and was active in commercialization of prominent drugs, including Avapro®, Pravachol®, Plavix®, Nexium®, Crestor®, Symbicort®, Brilinta® and Farxiga®. In his role at Radius, Ken is responsible for the design and implementation of the field sales organization, as well as delivery of all sales execution and performance goals. Before joining Radius, Ken was with AstraZeneca (AZ) for 12 years, most recently serving as Senior Director, Respiratory Biologics Marketing. Earlier in his career at AZ, he held several executive-level positions, including Executive Business Director, Primary Care Sales, where he shaped the company’s sales strategy and led teams across the U.S. to successfully deliver a broad portfolio of cardiovascular, respiratory and diabetes medicines. In addition, Ken served as AZ’s Executive Director of Commercial Insight, where he continually evolved sales and marketing operations, quantitative commercial analytics and a host of broader insight offerings to better fit the needs of the organization. Prior to joining AZ, Ken led a range of forecasting, promotional response and commercial analytic teams within Bristol-Myers Squibb for both global and U.S. marketing operations groups. During his time in the pharmaceutical industry, Ken has worked in both pharmaceutical client and agency organizations. He began his pharmaceutical career as a consultant working on global market analytics and product commercialization strategy development. He also was CEO of Genactis Inc., the U.S. arm of a multinational marketing research consultancy. Ken earned a B.A. in Sociology from Grinnell College and a M.S. in Criminal Justice from Rutgers University. 

Research Interest

Company’s sales strategy, Design and implementation of the field sales organization